Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial): Design and early dosimetric results of a randomized, multi-centre phase-III study

Ditte Sloth Moller, Tine Bjørn Nielsen, Carsten Brink, Lone Hoffmann, Christina Maria Lutz, Mikkel Drogemuller Lund, Olfred Hansen, Tine Schytte, Azza Ahmed Khalil, Marianne Marquard Knap, Christa Haugaard Nyhus, Wiviann Ottosson, Patrik Sibolt, Svetlana Borissova, Mirjana Josipovic, Gitte Persson, Ane Lindegaard Appelt

Research output: Contribution to journalJournal articleResearchpeer-review

24 Citations (Scopus)
115 Downloads (Pure)
Original languageEnglish
JournalRadiotherapy & Oncology
Volume124
Issue number2
Pages (from-to)311-317
ISSN0167-8140
DOIs
Publication statusPublished - Aug 2017

Keywords

  • NSCLC
  • Dose-escalation
  • Randomized phase-III trial

Cite this